Patents by Inventor Afssaneh Rahbar

Afssaneh Rahbar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of 2-alkoxyphenyl-substituted imidazotriazinones
    Publication number: 20080085897
    Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the treatment of cardiac insufficiency, cancer, bladder disorders, or prostate hyperplasia.
    Type: Application
    Filed: October 1, 2007
    Publication date: April 10, 2008
    Applicant: Bayer HealthCare AG
    Inventors: Ulrich Niewohner, Maria Niewohner, Erwin Bischoff, Helmut Haning, Afssaneh Rahbar, Tiemo-Joerg Bandel, Wolfgang Barth
  • Use of 2-alkoxyphenyl-substituted imidazotriazinones
    Patent number: 7276504
    Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.
    Type: Grant
    Filed: June 17, 2005
    Date of Patent: October 2, 2007
    Assignee: Bayer HealthCare AG
    Inventors: Maria Theresia Niewohner, legal representative, Erwin Bischoff, Helmut Haning, Afssaneh Rahbar, Tiemo-Joerg Bandel, Wolfgang Barth, Ulrich Niewohner, deceased
  • Use of 2-alkoxyphenyl-substituted imidazotriazinones
    Publication number: 20050234022
    Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.
    Type: Application
    Filed: June 17, 2005
    Publication date: October 20, 2005
    Applicant: Bayer HealthCare AG
    Inventors: Ulrich Niewohner, Maria Niewohner, Erwin Bischoff, Helmut Haning, Afssaneh Rahbar, Tiemo-Joerg Bandel, Wolfgang Barth
  • Use of 2-alkoxyphenol-substituted imidazotriazinones
    Patent number: 6930108
    Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.
    Type: Grant
    Filed: July 17, 2002
    Date of Patent: August 16, 2005
    Assignee: Bayer HealthCare AG
    Inventors: Maria Theresia Niewöhner, Erwin Bischoff, Helmut Haning, Afssaneh Rahbar, Tiemo-Joerg Bandel, Wolfgang Barth, Ulrich Niewöhner
  • Use of 2-alkoxyphenol-substituted imidazotriazinones
    Publication number: 20040235838
    Abstract: The present invention relates to the use of known 2-phenyl-substituted imidazotriazinones having short, unbranched alkyl radicals in the 9-position and cGMP PDE-inhibitory properties for the production of medicaments for the treatment of cardiac insufficiency, psoriasis, female infertility, cancer, diabetes, ophthalmic disorders such as glaucoma, disorders of gastric motility, cystic fibrosis, premature labour, pulmonary hypertension, bladder disorders, prostate hyperplasia, nitrate-induced tolerance, pre-eclampsia, alopecia, Parkinson's disease, pain, tinnitus or the renal syndrome.
    Type: Application
    Filed: June 18, 2004
    Publication date: November 25, 2004
    Inventors: Ulrich Niewohner, Maria Theresia Niewohner, Erwin Bischoff, Helmut Haning, Afssaneh Rahbar, Tiemo-Joerg Bandel, Wolfgang Barth
  • Novel use of 2-phenyl-substituted imidazotriazinones
    Publication number: 20040152700
    Abstract: The present invention relates to the use of PDE 5 inhibitors generally and in particular of 2-phenyl-substituted imidazotriazinones for the production of a medicament for improving the perception, concentration power, learning power and/or memory power, in particular for the treatment and/or prophylaxis of disorders of the perception, concentration power, learning power and/or memory power.
    Type: Application
    Filed: April 8, 2004
    Publication date: August 5, 2004
    Inventors: Ulrich Niewohner, Maria Theresia Niewohner, Erwin Bischoff, Helmut Haning, Afssaneh Rahbar, Tiemo-Jorg Bandel, Wolfgang Barth, Franz-Josef Van Der Staay
  • Derivatives of porphycene for photodynamic therapy of cancer
    Patent number: 5244671
    Abstract: New porphycene compounds useful as photodynamic therapy agents. The porphycene compounds have an active group capable of binding to proteins and peptides and facilitating decomposition of the porphycenes following therapy.
    Type: Grant
    Filed: January 29, 1991
    Date of Patent: September 14, 1993
    Assignee: Cytopharm, Inc.
    Inventors: Emanuel Vogel, Peter A. Koch, Afssaneh Rahbar, Alexander D. Cross